Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors
The calcitonin and amylin receptors (CTR and AMY receptors) are the drug targets for osteoporosis and diabetes treatment, respectively. Salmon calcitonin (sCT) and pramlintide were developed as peptide drugs that activate these receptors. However, next-generation drugs with improved receptor binding...
Main Author: | Sangmin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/9/1364 |
Similar Items
-
Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
by: Cajsa Aranäs, et al.
Published: (2021-06-01) -
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
by: David S. Mathiesen, et al.
Published: (2021-01-01) -
Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01) -
The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes
by: Toshio Sekiguchi
Published: (2018-11-01) -
Mice Lacking the Calcitonin Receptor Do Not Display Improved Bone Healing
by: Jessika Appelt, et al.
Published: (2021-09-01)